Major Events - Chuangsheng Group-B (06628) announced updated efficacy data for osemitamab triple therapy as a first-line treatment for gastric or gastroesophageal junction adenocarcinoma at ESMO Asia [1] - Strength Development (01277) plans to acquire 100% equity of Taiyuan Shidi for approximately 384 million yuan and acquire Dongzhimen property for a total of 86.33 million yuan [1] - Innovent Biologics (01801) completed a global strategic collaboration with Takeda Pharmaceutical and issued 6.9138 million shares under general authorization [1] - Ascentage Pharma-B (06855) received FDA and EMA approval for global registration of a Phase III clinical trial for Nilotinib as a first-line treatment for Ph+ ALL [1] - Baiao Saitou-B (02315) announced that its business partner IDEAYA received IND approval from the FDA for IDE034 [1] - Jinfang Pharmaceutical-B (02595) initiated a registration clinical trial for GFH375, the world's first oral KRAS G12D inhibitor in a controlled chemotherapy Phase III study [1] - Xixiangfeng Group (02473) signed a business cooperation agreement with Hello Car Rental to develop car rental services in designated cities under a "co-branded store" model [1] - International Commercial Settlement (00147) signed a computer chip sales agreement with Hong Kong Antarctic Light to seize growth opportunities in the IC chip market [1] - CSPC Pharmaceutical Group (01093) received clinical trial approval in the U.S. for a GLP-1/GIP receptor dual agonist injection [1] - MIRXES-B (02629) plans to collaborate with Crystal Technology to build an AI-enabled integrated "diagnosis and treatment" research and industrialization platform [1] - Zhengtong Automobile (01728) intends to invest approximately 816 million yuan to acquire Xiamen Xinda 4S dealership and automotive sales and export business [1] - Guorui Life (00108) plans to acquire 78.3% of Beijing Chunyu Tianxia Software for 269 million yuan [1] - Innovent Biologics (01801) successfully included seven innovative products (including new indications) in the 2025 National Medical Insurance Drug List [1] - Peijia Medical-B (09996) had its registration application for the TaurusNXT® "non-aldehyde cross-linked" transcatheter aortic valve replacement system accepted by the National Medical Products Administration [1] - Fosun Pharma (02196) had new drugs included in the National Medical Insurance Directory and commercial insurance innovative drug directory [1] - Junshi Biosciences (01877) had Tuoyi® new indications and Junshida® included in the National Medical Insurance Directory [1] - Valiant Biotech-B (09887) presented clinical data for LBL-034 at the 67th ASH Annual Meeting [1] - Canfite BioPharma (09926) had all approved indications for five marketed drugs successfully included in the latest National Medical Insurance Drug List [1] - Fuhong Hanlin (02696) had Fuzhuoning® (Citrus Acid Vovizili Capsules) included in the National Medical Insurance Drug List [1] - Green Leaf Pharmaceutical (02186) successfully included five new products in the 2025 National Medical Insurance Drug List or commercial insurance innovative drug directory [1] - Yinnuo Pharmaceutical-B (02591) had its core products included in the National Medical Insurance Drug List [1] Operating Performance - Poly Real Estate Group (00119) reported a contract sales amount of approximately 47.7 billion yuan for the first 11 months, a year-on-year decrease of 8.45% [2] - GAC Group (02238) reported November automobile sales of approximately 179,700 units, a year-on-year decline of 9.72% [2] - Xiehe New Energy (00182) reported an equity power generation of 697.23 GWh in November, a year-on-year increase of 7.77% [2]

Core Viewpoint - Xiamen Xinda plans to sell its entire automotive dealership business, which is expected to result in a loss of approximately 17.67 million yuan for the current fiscal year [2][3]. Group 1: Transaction Details - Xiamen Xinda will sell 100% equity of Xiamen Xinda International Trade Automotive Group Co., Ltd. and 100% equity of International Trade Automotive (Thailand) Co., Ltd. to a wholly-owned subsidiary of Zhengtong Automobile [2][3]. - The total transaction value is approximately 816 million yuan, with the core asset, Xinda International Trade Automotive, valued at about 790 million yuan [3]. - The financial impact of the transaction is a projected loss of 17.67 million yuan, not accounting for transitional profit and loss [3]. Group 2: Performance of Core Assets - Xinda International Trade Automotive reported a revenue of 8.82 billion yuan in 2024 but incurred a net loss of 48.66 million yuan [3]. - For the first half of 2025, the company achieved a revenue of 3.66 billion yuan, with a minimal net profit of 11,020 yuan [3]. Group 3: Strategic Rationale - The sale is part of a commitment made by the controlling shareholder in 2022 to resolve overlapping business operations in the automotive dealership sector [4][5]. - The company aims to refocus its resources on core business areas and enhance operational efficiency [5][6]. - The transaction will also involve the transfer of certain fundraising projects related to the automotive business [5]. Group 4: Approval Process - The transaction is subject to approval by Xiamen Xinda's shareholders and requires the counterparty to fulfill regulatory procedures [7].

Core Viewpoint - The company, Zhengtong Automobile, is expanding its operations through acquisitions in both China and Thailand, aiming to enhance its market presence and operational scale in the automotive industry. Group 1: Acquisition Details - Zhengtong Automobile's subsidiary, Xiamen Zhengtong, has entered into an agreement to acquire 100% of the equity of Xinda Guomao Automobile for approximately RMB 793.49 million in China [1] - The company’s other subsidiary, Tongda Group, is set to acquire 100% of the issued share capital of Guomao Automobile (Thailand) for approximately RMB 22.13 million [1] - The acquisitions are contingent upon meeting all necessary conditions, including obtaining independent shareholder approval [1] Group 2: Business Operations - Xinda Guomao Automobile Group operates nearly 50 automotive 4S stores, new energy vehicle experience centers, and body repair centers, distributing 29 brands including BMW, Audi, and Tesla, making it one of the leading 4S dealers in Fujian Province, China [2] - The group is involved in both traditional fuel and new energy vehicle 4S dealership businesses, as well as import and export operations for vehicles, positioning itself as a top dealer in Fujian Province [3] Group 3: Strategic Advantages - The group has established a strong early presence in new energy vehicles and international business, with several new energy brands under its umbrella [3] - The acquisition of Guomao Automobile (Thailand) marks a significant step in the company's overseas dealership network, enhancing its international business layout [3] - Post-acquisition, the company aims to rapidly expand its regional footprint, operational scale, and market share, while integrating overseas channels and customer networks to facilitate international market entry [3]

格隆汇12月5日丨正通汽车(01728.HK)宣布，于2025年12月5日(交易时段後)，厦门正通(公司的全资附属 公司)与厦门信达及信达国贸汽车订立收购协议(中国)，以约人民币7.93亿元的临时收购价(中国)收购信 达国贸汽车100%的股权。信达国贸汽车为厦门信达于中国从事4S经销业务以及汽车销售及出口业务的 控股公司。 信达国贸汽车集团与国贸汽车(泰国)合共代表厦门信达旗下全部4S经销业务以及汽车销售及出口业务。 有关收购事项(中国)及收购事项(泰国)仅于收购事项(中国)及收购事项(泰国)的所有先决条件(包括取得独 立股东批准)获达成时，方会进行。 同日，通达集团(公司的全资附属公司)及升涛(公司另一全资附属公司)与信达诺及信达(新加坡)和国贸汽 车(泰国)订立收购协议(泰国)，以约人民币2213万元的临时收购价(泰国)收购国贸汽车(泰国)100%的已发 行股本。国贸汽车(泰国)现处于在泰国开设汽车销售门店的起步阶段，尚未展开实质性业务营运。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 China ZhengTong Auto Services Holdings Limited 中國正通汽車服務控股有限公司 （根據開曼群島法律註冊成立的有限公司） （股份代號：1728） 主要及關連交易 獨立財務顧問 收購廈門信達4S經銷店以及汽車銷售及出口業務 董事會欣然宣佈，於2025年12月5日（交易時段後），廈門正通（本公司的全資附屬 公司）與廈門信達及信達國貿汽車訂立收購協議（中國），以約人民幣793.49百萬 元的臨時收購價（中國）收購信達國貿汽車100%的股權。信達國貿汽車為廈門信 達於中國從事4S經銷業務以及汽車銷售及出口業務的控股公司。 – 1 – 同日，通達集團（本公司的全資附屬公司）及升濤（本公司另一全資附屬公司）與信 達諾及信達（新加坡）和國貿汽車（泰國）訂立收購協議（泰國），以約人民幣22.13 百萬元的臨時收購價（泰國）收購國貿汽車（泰國）100%的已發行股本。國貿汽車 （泰 ...

致：香港交易及結算所有限公司 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 公司名稱: 中國正通汽車服務控股有限公司 呈交日期: 2025年12月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01728 | 說明 | 普通股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 20,000,000,000 | HKD | | 0.1 | HKD | | 2,000,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 20,000,000,000 | HKD | | 0.1 | HKD | | 2,000,000, ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 中國正通汽車服務控股有限公司 呈交日期: 2025年11月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01728 | 說明 | 普通股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 20,000,000,000 | HKD | | 0.1 | HKD | | 2,000,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 20,000,000,000 | HKD | | 0.1 | HKD | | 2,000,000, ...

Core Viewpoint - Dongzheng Finance (02718.HK) is set to issue 533 million shares with a price range of HKD 4.20 to HKD 6.30, targeting both local and international investors, and plans to list on March 26, 2019 [1][2]. Group 1: Company Overview - Dongzheng Finance is a subsidiary of Zhengtong Automotive and is the only automotive finance company in China licensed and regulated by the China Banking and Insurance Regulatory Commission [2]. - The company specializes in providing financial products and services for the purchase of luxury brand vehicles [2]. - As of December 31, 2018, the company had a dealer network of 1,280 dealers covering 182 cities in China, including all four first-tier cities and various second and third-tier cities [3]. Group 2: Financial Performance - In 2018, the company issued 31,577 retail loans for luxury vehicle purchases, totaling a principal amount of RMB 6.108 billion, which accounted for 75.7% of the total retail loans issued by the company [2]. - The company reported revenues of RMB 3.32 billion, RMB 4.62 billion, and RMB 8.16 billion for the years 2016, 2017, and 2018, respectively, with net profits of RMB 1.75 billion, RMB 2.61 billion, and RMB 4.53 billion during the same period [3]. Group 3: Use of Proceeds - The net proceeds from the offering are estimated to be approximately HKD 2.672 billion, with 70% allocated for expanding business involving external clients, 15% for self-operated retail loans to Zhengtong Automotive clients, 5% for developing technology and operational capabilities, and 10% for general working capital [3].

Core Insights - The logistics industry is witnessing a significant shift towards the adoption of unmanned delivery vehicles, with major companies making large-scale purchases to enhance efficiency and reduce costs [1][4][5]. Group 1: Unmanned Vehicle Procurement - China Post has initiated a procurement project for 7,000 unmanned vehicles, including various sizes and services, with a framework agreement lasting four years [1][2]. - JD Logistics plans to purchase 3 million robots, 1 million unmanned vehicles, and 100,000 drones over the next five years to strengthen its position in smart logistics [1][4]. - Companies like Cainiao and Shentong Express are also investing in unmanned vehicles, with Shentong aiming to deploy 2,000 unmanned vehicles by the end of the year [1][5]. Group 2: Market Trends and Growth - The unmanned delivery vehicle market is expected to experience explosive growth by 2025, driven by technological advancements, cost reductions, and increased demand in the instant retail market [4][6]. - As of mid-2025, over 100 cities in China have opened road rights for unmanned delivery vehicles, with the total number of such vehicles exceeding 6,000, marking a 50% increase from 2024 [6][8]. Group 3: Cost Efficiency and Operational Benefits - Unmanned vehicles can significantly reduce delivery costs, with reports indicating a decrease of 30%-50% in last-mile delivery expenses [8][10]. - Companies like Zhongtong Express have noted that using unmanned vehicles can lower costs by 6-7 cents per package, enhancing operational efficiency [5][10]. Group 4: Expansion Beyond Traditional Delivery - The application of unmanned vehicles is expanding beyond the express delivery sector into urban logistics and instant delivery markets, indicating a potential for exponential growth [10][12]. - White Rhino is diversifying its operations to include campus delivery networks and retail replenishment, showcasing the versatility of unmanned vehicles in various logistics scenarios [12].

| 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01728 | 說明 | 普通股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 20,000,000,000 | HKD | | 0.1 | HKD | | 2,000,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 20,000,000,000 | HKD | | 0.1 | HKD | | 2,000,000,000 | 本月底法定/註冊股本總額： HKD 2,000,000,000 FF301 第 1 頁 共 10 頁 v 1.1.1 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 致： ...